Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA
Cadence
Remote care management and clinician-supervised medication pathways for chronic cardiometabolic conditions.
What they do
Cadence partners with health systems to combine remote monitoring software with clinical care team services. Its HypertensionOS prescription software was selected for the FDA TEMPO pilot to support clinician-supervised medication management for Stage 2 hypertension within defined safeguards. Pilot selection is not FDA clearance or a Medicare coverage determination.
The record
- Vertical
- Remote Monitoring & Wearables
- Sub-segment
- Remote patient monitoring
- Product type
- Service
- Stage
- Series B
- Headquarters
- New York, United States
- Region
- North America
- Founded
- 2021
- Total funding
- $141M raised
Notable investors: Coatue Management, General Catalyst, Thrive Capital.
Also in Remote Monitoring & Wearables
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The Top Remote Patient Monitoring Platforms of 2026
A hospital bed is the most expensive real estate in medicine. These seven platforms are moving serious care into the living room, and getting paid for it.
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
The 2026 CPT Code Changes for Remote Monitoring: What They Mean for Your Reimbursement Model
Dr. Dereck Mush, MD, MBA